Links to all GeneRIF Items | 1728 |
PubMed (Gene Name) | Literature evidence |
|---|---|
| 12163326 (NQO1) | NQO1-Pro/Pro genotype is a risk factor for lung adenocarcinoma development |
| 14592434 (NQO1) | These results provide the first evidence of a proximal repressor region exerting a negative role on the regulation of the hNQO1 promoter in small cell lung carcinoma. |
| 15498787 (NQO1) | The observed risk reductions of lung cancer may be attributable to the greatly reduced procarcinogen activating of NAD(P)H:quinone oxidoreductase 1 in individuals with at least one copy of the T allele. |
| 18798003 (NQO1) | genetic polymorphisms for NQO1, CYP2E1, and ALDH2 synergistically with cumulative smoking amounts and alcohol drinking levels interact in the carcinogenesis of lung cancer in Koreans. |
| 19596483 (NQO1) | genetic polymorphisms affects treatment outcome after postoperative radiation therapy in completely resected non-small cell lung cancer |
| 20091863 (NQO1) | Modifying effect of NQO1 polymorphisms on the risk of early-onset lung cancer. |
| 21479364 (NQO1) | NQO1*2/*2 may be an independent predictor of poor overall survival in individuals with resected stages II and IIIa non-small cell lung cancer |
| 21964527 (NQO1) | C609T polymorphism of NAD(P)H quinone oxidoreductase 1 is associated with response to amrubicin therapy in lung cancer. |
| 22393995 (NQO1) | meta-analysis suggests that the variant NQO1 C609T genotype may affect individual susceptibility to lung cancer; this meta-analysis suggests that the NQO1 609T allele is a low penetrant risk factor for developing lung cancer in Chinese |
| 23110137 (NQO1) | No association between NADPH quinone oxidoreductase 1 (NQO1) gene C609T polymorphism and lung cancer in a Chinese case-control study and a larger meta-analysis. |
| 23852860 (NQO1) | Studies suggest that NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism might associate with lung cancer risk in Caucasians. |
| 25222473 (NQO1) | NQO1 expression was significantly more frequent in non-small cell lung carcinoma patients with KRAS mutations, suggesting that oxidative stress may be important in the pathogenesis, worse prognosis, and resistance to treatment reported in these patients. |
| 25231218 (NQO1) | NQO1 plays an important role in the progression of small cell lung cancer. |
| 25400754 (NQO1) | NQO1 genetic polymorphisms were not associated with prognosis in limited-stage small cell lung cancer. |
| 25729241 (NQO1) | The results suggests that haplotypes of the NQO1 gene play an important role in the development of lung cancer by interaction with smoking. |
| 25880877 (NQO1) | NQO1 is upregulated in NSCLC, and it may be a useful poor prognostic biomarker and a potential therapeutic target for patients with non-small cell lung cancer |
| 26452990 (NQO1) | Flavin reductase and calreticulin play key roles in the development of pemetrexed-associated resistance in lung adenocarcinoma cells. |